<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" version="2.0">

<channel>
	<title>Medical Dynamics</title>
	
	<link>http://www.rxmedyn.com/blog</link>
	<description>Just another WordPress weblog</description>
	<lastBuildDate>Wed, 10 Mar 2010 15:25:53 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/MedicalDynamics" /><feedburner:info xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" uri="medicaldynamics" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><feedburner:emailServiceId xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0">MedicalDynamics</feedburner:emailServiceId><feedburner:feedburnerHostname xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0">http://feedburner.google.com</feedburner:feedburnerHostname><item>
		<title>Top Industry News – March 10, 2010</title>
		<link>http://www.rxmedyn.com/blog/2010/03/top-industry-news-march-10-2010/</link>
		<comments>http://www.rxmedyn.com/blog/2010/03/top-industry-news-march-10-2010/#comments</comments>
		<pubDate>Wed, 10 Mar 2010 15:25:53 +0000</pubDate>
		<dc:creator>Rxmedyn</dc:creator>
				<category><![CDATA[Industry Stories]]></category>

		<guid isPermaLink="false">http://www.rxmedyn.com/blog/?p=879</guid>
		<description><![CDATA[Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech
Cellzome Announces Second Major Strategic Drug Discovery Alliance with
Botox (OnabotulinumtoxinA) Receives FDA Approval for Treatment of Upper Limb Spasticity in Adults
Quantity vs. Quality: Long-Term Use of Bone-Building Osteoporosis Drugs
Transgene Signs An Exclusive Option Agreement With Novartis For Tg 4010
Push to Cure Rare Diseases
]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.worldpharmanews.com/content/view/1148/1/">Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech</a></p>
<p><a href="http://www.pharmalive.com/News/index.cfm?articleid=690400">Cellzome Announces Second Major Strategic Drug Discovery Alliance with</a></p>
<p><a href="http://www.pharmalive.com/News/index.cfm?articleid=690373">Botox (OnabotulinumtoxinA) Receives FDA Approval for Treatment of Upper Limb Spasticity in Adults</a></p>
<p><a href="http://www.pharmalive.com/News/index.cfm?articleid=690452">Quantity vs. Quality: Long-Term Use of Bone-Building Osteoporosis Drugs</a><span id="more-879"></span></p>
<p><a href="http://www.pharmalive.com/News/Index.cfm?articleid=690386">Transgene Signs An Exclusive Option Agreement With Novartis For Tg 4010</a></p>
<p><a href="http://online.wsj.com/article/SB10001424052748704145904575111943356541152.html">Push to Cure Rare Diseases</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.rxmedyn.com/blog/2010/03/top-industry-news-march-10-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Top Industry News – March 9, 2010</title>
		<link>http://www.rxmedyn.com/blog/2010/03/top-industry-news-march-9-2010/</link>
		<comments>http://www.rxmedyn.com/blog/2010/03/top-industry-news-march-9-2010/#comments</comments>
		<pubDate>Tue, 09 Mar 2010 14:59:56 +0000</pubDate>
		<dc:creator>Rxmedyn</dc:creator>
				<category><![CDATA[Industry Stories]]></category>

		<guid isPermaLink="false">http://www.rxmedyn.com/blog/?p=877</guid>
		<description><![CDATA[Sanofi and Merck Link Up To Form Animal Health Giant
Genmab Shares Sink As Cancer Drug Fails in Phase III Study
The Potential For Using Algae To Produce Human Therapeutic Proteins
Science World Charmed By Snake Venom
Chelsea Adds $18M, Amended Droxidopa Study Nears Finish
]]></description>
			<content:encoded><![CDATA[<p><a href="http://pharmatimes.com/WorldNews/article.aspx?id=17524">Sanofi and Merck Link Up To Form Animal Health Giant</a></p>
<p><a href="http://pharmatimes.com/WorldNews/article.aspx?id=17514">Genmab Shares Sink As Cancer Drug Fails in Phase III Study</a></p>
<p><a href="http://www.medicalnewstoday.com/articles/181676.php">The Potential For Using Algae To Produce Human Therapeutic Proteins</a></p>
<p><a href="http://www.medicalnewstoday.com/articles/181608.php">Science World Charmed By Snake Venom</a><span id="more-877"></span></p>
<p><a href="http://www.pharmacychoice.com/News/article.cfm?Article_ID=544965">Chelsea Adds $18M, Amended Droxidopa Study Nears Finish</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.rxmedyn.com/blog/2010/03/top-industry-news-march-9-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Top Industry Stories – March 8, 2010</title>
		<link>http://www.rxmedyn.com/blog/2010/03/top-industry-stories-march-8-2010/</link>
		<comments>http://www.rxmedyn.com/blog/2010/03/top-industry-stories-march-8-2010/#comments</comments>
		<pubDate>Mon, 08 Mar 2010 15:47:59 +0000</pubDate>
		<dc:creator>Rxmedyn</dc:creator>
				<category><![CDATA[Industry Stories]]></category>

		<guid isPermaLink="false">http://www.rxmedyn.com/blog/?p=874</guid>
		<description><![CDATA[Roche Stops RA Drug Development After Deaths
Pfizer Brings Out Big Guns to Woo Ratiopharm
AstraZeneca Shares Fall After Setback for Colon Cancer Drug
Xenoport, Inc., Restructures to Focus on Key Programs; Includes An Overall Reduction of 50% of XenoPort&#8217;s Workforce
Disciplined Physicians Used as &#8216;Drug Mouthpieces&#8217; by Pharmaceutical Companies
Bald Women Lash Out at Sanofi-Avenits &#38; Taxotere
]]></description>
			<content:encoded><![CDATA[<p><a href="http://pharmatimes.com/WorldNews/article.aspx?id=17510">Roche Stops RA Drug Development After Deaths</a></p>
<p><a href="http://pharmatimes.com/WorldNews/article.aspx?id=17511">Pfizer Brings Out Big Guns to Woo Ratiopharm</a></p>
<p><a href="http://www.startribune.com/business/86849287.html">AstraZeneca Shares Fall After Setback for Colon Cancer Drug</a></p>
<p><a href="http://www.biospace.com/news_story.aspx?NewsEntityId=173047&amp;Source=TopBreaking">Xenoport, Inc., Restructures to Focus on Key Programs; Includes An Overall Reduction of 50% of XenoPort&#8217;s Workforce</a><span id="more-874"></span></p>
<p><a href="http://www.salem-news.com/articles/march082010/drug-doctors-ms.php">Disciplined Physicians Used as &#8216;Drug Mouthpieces&#8217; by Pharmaceutical Companies</a></p>
<p><a href="http://www.pharmalot.com/2010/03/bald-women-lash-out-at-sanofi-aventis-taxotere/?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+Pharmalot+%28Pharmalot%29">Bald Women Lash Out at Sanofi-Avenits &amp; Taxotere</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.rxmedyn.com/blog/2010/03/top-industry-stories-march-8-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Top Industry News – March 5, 2010</title>
		<link>http://www.rxmedyn.com/blog/2010/03/top-industry-news-march-5-2010/</link>
		<comments>http://www.rxmedyn.com/blog/2010/03/top-industry-news-march-5-2010/#comments</comments>
		<pubDate>Fri, 05 Mar 2010 16:19:23 +0000</pubDate>
		<dc:creator>Rxmedyn</dc:creator>
				<category><![CDATA[Industry Stories]]></category>

		<guid isPermaLink="false">http://www.rxmedyn.com/blog/?p=872</guid>
		<description><![CDATA[BMS Says Five New Drugs Will Soften the Blow of Plavix
Pfizer, Bristol-Myers Say Clot Drug Meets Goals
Common Osteoporosis Drugs Are Associated With a Decrease in Risk of Breast Cancer
Anavex Comments on Failure of Pfizer and Medivation&#8217;s Alzheimer&#8217;s Investigational Drug Dimebon

DTC Spending Stabilized in 2009 Amid Strong Growth for Cable, Internet Adspend
Merck &#8211; Vioxx: Big Pain [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://pharmatimes.com/WorldNews/article.aspx?id=17504">BMS Says Five New Drugs Will Soften the Blow of Plavix</a></p>
<p><a href="http://pharmalive.com/News/index.cfm?articleid=689492">Pfizer, Bristol-Myers Say Clot Drug Meets Goals</a></p>
<p><a href="http://pharmalive.com/News/index.cfm?articleid=689455">Common Osteoporosis Drugs Are Associated With a Decrease in Risk of Breast Cancer</a></p>
<p><a href="http://www.worldpharmanews.com/content/view/1138/1/">Anavex Comments on Failure of Pfizer and Medivation&#8217;s Alzheimer&#8217;s Investigational Drug Dimebon</a></p>
<p><span id="more-872"></span></p>
<p><a href="http://www.mmm-online.com/dtc-spending-stabilized-in-2009-amid-strong-growth-for-cable-internet-adspend/article/165030/?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+MMMNews+%28MMM+News%29">DTC Spending Stabilized in 2009 Amid Strong Growth for Cable, Internet Adspend</a></p>
<p><a href="http://pharmagossip.blogspot.com/2010/03/merck-vioxx-big-pain-down-under.html">Merck &#8211; Vioxx: Big Pain Down Under</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.rxmedyn.com/blog/2010/03/top-industry-news-march-5-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Top Industry Stories – March 4, 2010</title>
		<link>http://www.rxmedyn.com/blog/2010/03/top-industry-stories-march-4-2010/</link>
		<comments>http://www.rxmedyn.com/blog/2010/03/top-industry-stories-march-4-2010/#comments</comments>
		<pubDate>Thu, 04 Mar 2010 15:36:17 +0000</pubDate>
		<dc:creator>Rxmedyn</dc:creator>
				<category><![CDATA[Industry Stories]]></category>

		<guid isPermaLink="false">http://www.rxmedyn.com/blog/?p=868</guid>
		<description><![CDATA[Disappointment at Failure of Pfizer/Medivation’s Alzheimer’s Drug
Teva Regains Exclusivity on Merck Meds
Sanofi’s Cabazitaxel Improves Survival in Prostate Cancer Patients
75 Percent Of Drug Companies Formally Manage Investigator-Initiated Trials
Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories&#8217; Crinone Progesterone Gel Product Line
]]></description>
			<content:encoded><![CDATA[<p><a href="http://pharmatimes.com/WorldNews/article.aspx?id=17502">Disappointment at Failure of Pfizer/Medivation’s Alzheimer’s Drug</a></p>
<p><a href="http://www.fiercepharma.com/story/teva-regains-exclusivity-merck-meds/2010-03-03?utm_medium=rss&amp;utm_source=rss">Teva Regains Exclusivity on Merck Meds</a></p>
<p><a href="http://pharmatimes.com/WorldNews/article.aspx?id=17501">Sanofi’s Cabazitaxel Improves Survival in Prostate Cancer Patients</a></p>
<p><a href="http://www.medicalnewstoday.com/articles/181135.php">75 Percent Of Drug Companies Formally Manage Investigator-Initiated Trials</a><span id="more-868"></span></p>
<p><a href="http://pharmalive.com/News/index.cfm?articleid=689177">Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories&#8217; Crinone Progesterone Gel Product Line</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.rxmedyn.com/blog/2010/03/top-industry-stories-march-4-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Top Industry News, March 3, 2010</title>
		<link>http://www.rxmedyn.com/blog/2010/03/top-industry-news-march-3-2010/</link>
		<comments>http://www.rxmedyn.com/blog/2010/03/top-industry-news-march-3-2010/#comments</comments>
		<pubDate>Wed, 03 Mar 2010 15:02:03 +0000</pubDate>
		<dc:creator>Rxmedyn</dc:creator>
				<category><![CDATA[Industry Stories]]></category>

		<guid isPermaLink="false">http://www.rxmedyn.com/blog/?p=863</guid>
		<description><![CDATA[FDA Urged To Probe Digital Marketing by Drugmakers
FDA Advisory Committee Recommends Approval of Belatacept, an Investigational Agent for Prophylaxis of Acute Rejection in De Novo Kidney Transplant Patients
Bristol-Myers Squibb Promotes President to Chief Executive
Could Anti-Inflammatory Drugs Break Link Between Fat, Diseases?
Alzheimer&#8217;s Drug Falls Short 
The Benefits of Popping an Aspirin (and Some Risks)
]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://http://pharmatimes.com/WorldNews/article.aspx?id=17485">FDA Urged To Probe Digital Marketing by Drugmakers</a></strong></p>
<p><strong><a href="http://FDA Advisory Committee Recommends Approval of Belatacept, an Investigational Agent for Prophylaxis of Acute Rejection in De Novo Kidney Transplant Patients">FDA Advisory Committee Recommends Approval of Belatacept, an Investigational Agent for Prophylaxis of Acute Rejection in De Novo Kidney Transplant Patients</a></strong></p>
<p><strong><a href="http://http://www.nytimes.com/2010/03/03/business/03bristol.html?ref=todayspaper">Bristol-Myers Squibb Promotes President to Chief Executive</a></strong></p>
<p><strong><a href="http://http://www.usatoday.com/news/health/2010-03-02-fat-inflammation_N.htm">Could Anti-Inflammatory Drugs Break Link Between Fat, Diseases?</a><span id="more-863"></span></strong></p>
<p><strong><a href="http://http://online.wsj.com/article/SB10001424052748703862704575099320507972894.html?mod=WSJ_latestheadlines">Alzheimer&#8217;s Drug Falls Short </a></strong></p>
<p><strong><a href="http://http://www.usnews.com/health/managing-your-healthcare/heart/articles/2010/03/02/the-benefits-of-popping-an-aspirin-and-some-risks.html">The Benefits of Popping an Aspirin (and Some Risks)</a></strong></p>
]]></content:encoded>
			<wfw:commentRss>http://www.rxmedyn.com/blog/2010/03/top-industry-news-march-3-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Top Industry Stories – March 2, 2010</title>
		<link>http://www.rxmedyn.com/blog/2010/03/top-industry-stories-march-2-2010/</link>
		<comments>http://www.rxmedyn.com/blog/2010/03/top-industry-stories-march-2-2010/#comments</comments>
		<pubDate>Tue, 02 Mar 2010 15:40:25 +0000</pubDate>
		<dc:creator>Rxmedyn</dc:creator>
				<category><![CDATA[Industry Stories]]></category>

		<guid isPermaLink="false">http://www.rxmedyn.com/blog/?p=860</guid>
		<description><![CDATA[Merck’s Millipore Bid May Leave Investors Waiting
Synta Pharmaceuticals Gets FDA Nod to Resume Developing Cancer Drug
Funds Boost Research into Causes, Interventions for Age-Related Cognitive Decline
FDA Approves Exalgo Extended-Release Tablets
Med Ad News&#8217; 21st Annual Manny Awards Will Honor Healthcare Advertising Agencies
]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.businessweek.com/news/2010-03-02/merck-s-millipore-bid-may-leave-investors-waiting-update1-.html">Merck’s Millipore Bid May Leave Investors Waiting</a></p>
<p><a href="http://www.biospace.com/news_story.aspx?NewsEntityId=172387&amp;Source=TopBreaking">Synta Pharmaceuticals Gets FDA Nod to Resume Developing Cancer Drug</a></p>
<p><a href="http://www.worldpharmanews.com/content/view/1133/1/">Funds Boost Research into Causes, Interventions for Age-Related Cognitive Decline</a></p>
<p><a href="http://www.pharmalive.com/News/index.cfm?articleid=688394">FDA Approves Exalgo Extended-Release Tablets</a><span id="more-860"></span></p>
<p><a href="http://www.pharmalive.com/News/index.cfm?articleid=688188">Med Ad News&#8217; 21st Annual Manny Awards Will Honor Healthcare Advertising Agencies</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.rxmedyn.com/blog/2010/03/top-industry-stories-march-2-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Top Industry Stories – March 1, 2010</title>
		<link>http://www.rxmedyn.com/blog/2010/03/top-industry-stories-march-1-2010/</link>
		<comments>http://www.rxmedyn.com/blog/2010/03/top-industry-stories-march-1-2010/#comments</comments>
		<pubDate>Mon, 01 Mar 2010 16:52:16 +0000</pubDate>
		<dc:creator>Rxmedyn</dc:creator>
				<category><![CDATA[Industry Stories]]></category>

		<guid isPermaLink="false">http://www.rxmedyn.com/blog/?p=858</guid>
		<description><![CDATA[US Acts to Fast-track New Drugs
Merck Announces Robust Integrated Pipeline With More Than 20 Medicines and Vaccines in Late-Stage Development
Top Pharmaceutical and Biotech Companies Face Slow Down in Sales Growth Over 2008–14
GlaxoSmithKline Responds to US Senate Committee on Finance Report on Avandia
Boehringer Ingelheim&#8217;s Pradaxa Will Garner Blockbuster Sales of $1.3 Billion by 2018 in the [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://pharmatimes.com/WorldNews/article.aspx?id=17472">US Acts to Fast-track New Drugs</a></p>
<p><a href="http://pharmalive.com/News/index.cfm?articleid=688086">Merck Announces Robust Integrated Pipeline With More Than 20 Medicines and Vaccines in Late-Stage Development</a></p>
<p><a href="http://www.bionity.com/news/e/114108/">Top Pharmaceutical and Biotech Companies Face Slow Down in Sales Growth Over 2008–14</a></p>
<p><a href="http://www.worldpharmanews.com/content/view/1131/1/">GlaxoSmithKline Responds to US Senate Committee on Finance Report on Avandia</a><span id="more-858"></span></p>
<p><a href="http://www.pharmainfo.net/pharma-industry-news/03/01/2010/boehringer-ingelheims-pradaxa-will-garner-blockbuster-sales-13-billi">Boehringer Ingelheim&#8217;s Pradaxa Will Garner Blockbuster Sales of $1.3 Billion by 2018 in the Atrial Fibrillation Drug</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.rxmedyn.com/blog/2010/03/top-industry-stories-march-1-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Top Industry News – February 26, 2010</title>
		<link>http://www.rxmedyn.com/blog/2010/02/top-industry-news-february-26-2010/</link>
		<comments>http://www.rxmedyn.com/blog/2010/02/top-industry-news-february-26-2010/#comments</comments>
		<pubDate>Fri, 26 Feb 2010 16:17:19 +0000</pubDate>
		<dc:creator>Rxmedyn</dc:creator>
				<category><![CDATA[Industry Stories]]></category>

		<guid isPermaLink="false">http://www.rxmedyn.com/blog/?p=856</guid>
		<description><![CDATA[Regulus and Glaxo Will Work on Hepatitis C Drugs
Lilly Settlement to Fund MT Mental Health Services
KV to Close Ethex Unit and Plead Guilty to Charges
Philippines to Lower Prices on More Medicines
New Data Demonstrates Early Treatment with a Combination of Enbrel and Methotrexate Can Prevent Rheumatoid Arthritis Progression with Sustained Remission at Two Years
]]></description>
			<content:encoded><![CDATA[<p><a href="http://pharmalive.com/News/index.cfm?articleid=687590">Regulus and Glaxo Will Work on Hepatitis C Drugs</a></p>
<p><a href="http://pharmalive.com/News/index.cfm?articleid=687574">Lilly Settlement to Fund MT Mental Health Services</a></p>
<p><a href="http://www.drugs.com/news/kv-close-ethex-unit-plead-guilty-charges-22887.html?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+Drugscom-HeadlineNews+%28Drugs.com+-+Headline+News%29">KV to Close Ethex Unit and Plead Guilty to Charges</a></p>
<p><a href="http://www.drugs.com/news/philippines-lower-prices-more-medicines-22884.html?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+Drugscom-HeadlineNews+%28Drugs.com+-+Headline+News%29">Philippines to Lower Prices on More Medicines</a><span id="more-856"></span></p>
<p><a href="http://pharmalive.com/News/Index.cfm?articleid=687641">New Data Demonstrates Early Treatment with a Combination of Enbrel and Methotrexate Can Prevent Rheumatoid Arthritis Progression with Sustained Remission at Two Years</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.rxmedyn.com/blog/2010/02/top-industry-news-february-26-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Top Industry Stories – February 25, 2010</title>
		<link>http://www.rxmedyn.com/blog/2010/02/top-industry-stories-february-25-2010/</link>
		<comments>http://www.rxmedyn.com/blog/2010/02/top-industry-stories-february-25-2010/#comments</comments>
		<pubDate>Thu, 25 Feb 2010 15:22:32 +0000</pubDate>
		<dc:creator>Rxmedyn</dc:creator>
				<category><![CDATA[Industry Stories]]></category>

		<guid isPermaLink="false">http://www.rxmedyn.com/blog/?p=854</guid>
		<description><![CDATA[GSK Says Report on Avandia Ignores &#8220;Scientifically Sound&#8221; Info
Genentech Announces Positive Results of Avastin Phase III Study in Women with Advanced Ovarian Cancer
Pfizer&#8217;s Prevnar 13 Recommended by CDC&#8217;s Advisory Committee On Immunization Practices
Panel Recommends Annual Flu Vaccinations For All
]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.pharmatimes.com/WorldNews/article.aspx?id=17462">GSK Says Report on Avandia Ignores &#8220;Scientifically Sound&#8221; Info</a></p>
<p><a href="http://www.biospace.com/news_story.aspx?NewsEntityId=171893&amp;Source=TopBreaking">Genentech<strong> </strong>Announces Positive Results of Avastin Phase III Study in Women with Advanced Ovarian Cancer</a></p>
<p><a href="http://www.worldpharmanews.com/content/view/1128/1/">Pfizer&#8217;s Prevnar 13 Recommended by CDC&#8217;s Advisory Committee On Immunization Practices</a></p>
<p><a href="http://www.washingtonpost.com/wp-dyn/content/article/2010/02/24/AR2010022404361.html">Panel Recommends Annual Flu Vaccinations For All</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.rxmedyn.com/blog/2010/02/top-industry-stories-february-25-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
